Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

NYSE:AMTM - New York Stock Exchange, Inc. - US0239391016 - Common Stock - Currency: USD

20.66  +0.3 (+1.47%)

After market: 20.6 -0.06 (-0.29%)

Fundamental Rating

3

Overall AMTM gets a fundamental rating of 3 out of 10. We evaluated AMTM against 81 industry peers in the Professional Services industry. Both the profitability and financial health of AMTM have multiple concerns. AMTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AMTM had negative earnings in the past year.
In the past year AMTM had a positive cash flow from operations.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

AMTM has a worse Return On Assets (0.14%) than 62.96% of its industry peers.
AMTM's Return On Equity of 0.37% is on the low side compared to the rest of the industry. AMTM is outperformed by 62.96% of its industry peers.
With a Return On Invested Capital value of 2.31%, AMTM is not doing good in the industry: 61.73% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for AMTM is significantly below the industry average of 12.78%.
Industry RankSector Rank
ROA 0.14%
ROE 0.37%
ROIC 2.31%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin of AMTM (0.15%) is worse than 61.73% of its industry peers.
AMTM has a Operating Margin (2.57%) which is in line with its industry peers.
In the last couple of years the Operating Margin of AMTM has remained more or less at the same level.
AMTM has a worse Gross Margin (10.06%) than 86.42% of its industry peers.
In the last couple of years the Gross Margin of AMTM has declined.
Industry RankSector Rank
OM 2.57%
PM (TTM) 0.15%
GM 10.06%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

2

2. Health

2.1 Basic Checks

AMTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMTM has been increased compared to 1 year ago.
AMTM has a better debt/assets ratio than last year.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

AMTM has an Altman-Z score of 1.47. This is a bad value and indicates that AMTM is not financially healthy and even has some risk of bankruptcy.
AMTM's Altman-Z score of 1.47 is on the low side compared to the rest of the industry. AMTM is outperformed by 67.90% of its industry peers.
The Debt to FCF ratio of AMTM is 17.10, which is on the high side as it means it would take AMTM, 17.10 years of fcf income to pay off all of its debts.
AMTM has a Debt to FCF ratio of 17.10. This is in the lower half of the industry: AMTM underperforms 64.20% of its industry peers.
AMTM has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
AMTM's Debt to Equity ratio of 1.05 is on the low side compared to the rest of the industry. AMTM is outperformed by 71.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF 17.1
Altman-Z 1.47
ROIC/WACC0.25
WACC9.15%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.56 indicates that AMTM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.56, AMTM perfoms like the industry average, outperforming 58.02% of the companies in the same industry.
A Quick Ratio of 1.56 indicates that AMTM should not have too much problems paying its short term obligations.
AMTM has a better Quick ratio (1.56) than 60.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.53% over the past year.
AMTM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.65%.
Measured over the past years, AMTM shows a quite strong growth in Revenue. The Revenue has been growing by 12.53% on average per year.
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.15%
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%70.2%

3.2 Future

The Earnings Per Share is expected to grow by 71.64% on average over the next years. This is a very strong growth
Based on estimates for the next years, AMTM will show a small growth in Revenue. The Revenue will grow by 2.66% on average per year.
EPS Next Y306.92%
EPS Next 2Y112.55%
EPS Next 3Y71.64%
EPS Next 5YN/A
Revenue Next Year2.5%
Revenue Next 2Y2.69%
Revenue Next 3Y2.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

AMTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 8.62, the valuation of AMTM can be described as very reasonable.
87.65% of the companies in the same industry are more expensive than AMTM, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.15. AMTM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 8.62
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMTM is valued a bit cheaper than the industry average as 60.49% of the companies are valued more expensively.
AMTM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AMTM is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.37
EV/EBITDA 13.52
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMTM's earnings are expected to grow with 71.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y112.55%
EPS Next 3Y71.64%

0

5. Dividend

5.1 Amount

AMTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMENTUM HOLDINGS INC

NYSE:AMTM (5/30/2025, 8:04:00 PM)

After market: 20.6 -0.06 (-0.29%)

20.66

+0.3 (+1.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)N/A N/A
Inst Owners55.74%
Inst Owner Change7.79%
Ins Owners0.55%
Ins Owner Change10.42%
Market Cap5.03B
Analysts75.38
Price Target24.77 (19.89%)
Short Float %5.78%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.23%
Min EPS beat(2)10.16%
Max EPS beat(2)10.29%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.07%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)0.09%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.69%
PT rev (3m)-11.69%
EPS NQ rev (1m)-0.74%
EPS NQ rev (3m)-3.49%
EPS NY rev (1m)0.36%
EPS NY rev (3m)0.28%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-1.24%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.62
P/S 0.45
P/FCF 18.37
P/OCF 17.24
P/B 1.14
P/tB N/A
EV/EBITDA 13.52
EPS(TTM)-0.05
EYN/A
EPS(NY)2.4
Fwd EY11.6%
FCF(TTM)1.12
FCFY5.44%
OCF(TTM)1.2
OCFY5.8%
SpS46.28
BVpS18.19
TBVpS-14.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.14%
ROE 0.37%
ROCE 2.92%
ROIC 2.31%
ROICexc 2.44%
ROICexgc 16.93%
OM 2.57%
PM (TTM) 0.15%
GM 10.06%
FCFM 2.43%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score6
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF 17.1
Debt/EBITDA 6.9
Cap/Depr 4.69%
Cap/Sales 0.16%
Interest Coverage 250
Cash Conversion 43.39%
Profit Quality 1651.14%
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 1.47
F-Score6
WACC9.15%
ROIC/WACC0.25
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.15%
EPS Next Y306.92%
EPS Next 2Y112.55%
EPS Next 3Y71.64%
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%70.2%
Revenue Next Year2.5%
Revenue Next 2Y2.69%
Revenue Next 3Y2.66%
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year105.96%
EBIT Next 3Y31.97%
EBIT Next 5YN/A
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A